イベントチャート

2018/06/11~2018/11/01

イベント情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2018
11/012,6372,6372,3002,300-7.52%128,400662億4000万-11.09%
11/01(空売り報告)Integrated Core Strategies (Asia) Pte. Ltd. 145,000株(0.5%)新規
10/31(IR情報)15:00 2018年12月期第3四半期決算参考資料
10/31(IR情報)15:00 平成30年12月期第3四半期決算短信〔日本基準〕(非連結)
10/312,4532,5262,4532,487+1.72%38,400716億2560万-4.49%
10/302,4312,4822,4212,445-0.45%45,100704億1600万-6.47%
10/292,4352,5172,4012,456+0.33%47,000707億3280万-6.33%
10/262,4422,4672,4002,448+0.41%61,100705億240万-6.81%
10/252,5052,5142,4302,438-4.58%43,600702億1440万-7.48%
10/242,5322,5622,5262,555+0.95%21,400735億8400万-3.44%
10/232,5602,5742,5312,531-1.44%40,000728億9280万-4.45%
10/222,5672,5822,5422,568-0.96%17,000739億5840万-3.09%
10/192,5612,5942,5582,5930%15,600746億7840万-2.15%
10/182,5792,6192,5782,593+0.27%32,700746億7840万-1.97%
10/172,5442,5902,5212,586+1.73%45,900744億7680万-1.97%
10/162,5332,5552,5212,542-0.47%31,200732億960万-3.38%
10/152,5662,5972,5452,554-0.39%36,300735億5520万-2.63%
10/122,5652,6062,5442,564-0.04%52,000738億4320万-1.95%
10/112,5552,5752,5102,565-2.66%74,600738億7200万-1.5%
10/102,7122,7122,6252,635-3.44%81,700758億8800万+1.54%
10/092,7762,7762,7002,729-2.12%46,000785億9520万+5.61%
10/052,7482,8102,7282,788+1.42%41,700802億9440万+8.48%
10/042,7402,7582,7092,749+0.99%49,900791億7120万+7.68%
10/032,6522,7342,6522,722+2.64%43,700783億9360万+7.29%
10/022,6672,6952,6432,652-2.39%65,100763億7760万+4.57%
10/012,7252,7672,7032,717-0.66%45,700782億4960万+7.05%
09/282,7472,7872,7052,735+0.59%56,600787億6800万+7.76%
09/272,7312,7312,6592,719-0.51%82,600783億720万+7.17%
09/262,7412,7712,7002,733+0.07%40,000787億1040万+7.9%
09/252,6682,7312,6632,731+3.6%104,400786億5280万+7.99%
09/212,5812,6502,5812,636+1.78%77,100759億1680万+4.4%
09/202,6782,6782,5812,590-2.7%80,600745億9200万+2.57%
09/192,7092,7092,6482,662-1.08%100,100766億6560万+5.3%
09/182,6322,6922,5952,691+2.28%79,300775億80万+6.45%
09/14(IR情報)15:00 人事異動のお知らせ
09/142,6022,6732,5952,631+2.14%118,200757億7280万+4.2%
09/132,5792,5902,5532,576+0.7%74,800741億8880万+2.1%
09/122,4712,5592,4542,558+3.56%118,600736億7040万+1.35%
09/112,4232,4902,4222,470+2.28%94,200711億3600万-2.18%
09/102,4092,4202,3912,415+0.25%68,300695億5200万-4.58%
09/072,3472,4092,3412,409+2.51%134,000693億7920万-5.05%
09/062,3422,3642,3312,350+0.47%49,300676億8000万-7.63%
09/052,3002,3502,2922,339+1.34%77,700673億6320万-8.45%
09/042,3342,3362,3052,308-0.99%85,400664億7040万-10.09%
09/032,3752,3752,3302,331-1.56%104,200671億3280万-9.76%
08/312,3582,3852,3522,368+0.3%76,600681億9840万-9.1%
08/302,3662,3832,3452,361-0.04%153,000679億9680万-10.06%
08/292,3572,3702,3502,362+0.08%210,300680億2560万-10.67%
08/282,4032,4252,3432,360-12.69%491,200679億6800万-11.24%
08/27(IR情報)15:00 抗HIV薬6品の日本国内における独占的開発・商業化権に関する契約及び独占的販売権に関する契約の解消に向けた意思確認書の締結について
08/272,7012,7072,6632,703+0.07%13,100778億4640万+1.2%
08/242,7422,7432,6812,701-0.63%18,700777億8880万+1.2%
08/232,7132,7492,7032,718+0.11%22,000782億7840万+1.95%
08/222,6212,7172,6212,715+3.71%35,700781億9200万+1.88%
08/212,6022,6232,5972,618-0.49%13,800753億9840万-1.69%
08/202,6202,6312,6052,6310%13,900757億7280万-1.24%
08/172,6302,6482,6122,631+0.04%15,600757億7280万-1.24%
08/162,6332,6642,6042,630-1.31%25,100757億4400万-1.31%
08/152,6492,6672,6172,665-0.07%21,200767億5200万+0.08%
08/142,5992,6672,5982,667+2.3%29,800768億960万+0.15%
08/132,5762,6142,5762,607+0.7%28,000750億8160万-2.18%
08/102,6042,6062,5672,589-0.19%28,400745億6320万-3%
08/092,5682,5982,5572,594+0.78%20,800747億720万-2.85%
08/082,6082,6252,5732,574-2.24%20,100741億3120万-3.78%
08/072,5612,6342,5612,633+2.97%25,300758億3040万-1.75%
08/062,5552,5872,5542,557-1.24%32,900736億4160万-4.63%
08/032,6112,6272,5832,589-1.26%35,000745億6320万-3.61%
08/022,6292,6842,6082,622-1.09%34,300755億1360万-2.56%
08/012,6492,6952,6492,651-1.78%60,600763億4880万-1.63%
07/312,7732,8232,6972,699-6.06%78,500777億3120万+0.07%
07/30(IR情報)15:00 2018年12月期第2四半期決算参考資料
07/30(IR情報)15:00 平成30年12月期第2四半期決算短信〔日本基準〕(非連結)
07/302,8702,8732,8032,873+0.1%99,400827億4240万+6.49%
07/272,8372,8812,7982,870+1.16%40,600826億5600万+6.61%
07/262,7862,8382,7272,837+3.05%35,200817億560万+5.58%
07/252,6922,7612,6772,753+3.61%48,300792億8640万+2.53%
07/242,6702,6702,6222,657+0.38%36,900765億2160万-1.08%
07/232,6002,6702,6002,647+0.57%23,900762億3360万-1.67%
07/202,6622,6812,6132,632-1.9%39,300758億160万-2.52%
07/192,6762,6962,6502,683+0.26%25,600772億7040万-0.89%
07/182,6482,6792,6312,676+1.29%18,400770億6880万-1.33%
07/172,6252,6622,6082,642+0.65%20,600760億8960万-2.8%
07/132,6312,6312,5802,625-0.72%39,800756億-3.56%
07/122,6182,6492,5922,644+2.01%33,600761億4720万-3.08%
07/112,6422,6702,5702,592-2.41%49,000746億4960万-5.09%
07/102,7332,7402,6552,656-2.82%39,400764億9280万-2.92%
07/092,6932,7342,6762,733+1.49%40,600787億1040万-0.18%
07/062,6492,6972,6242,693+2.67%21,600775億5840万-1.5%
07/052,6932,6932,6082,623-3.03%18,900755億4240万-4.13%
07/042,6882,7152,6852,705-0.51%22,800779億400万-1.42%
07/032,6422,7302,6422,719+2.68%40,500783億720万-0.98%
07/022,6922,7052,6392,648-1.63%24,700762億6240万-3.67%
06/292,7082,7312,6802,692-0.59%13,200775億2960万-2.36%
06/28(IR情報)15:00 NK-1受容体アンタゴニスト(JTS-661)の開発中止及びMenlo Therapeutics社とのライセンス契約の解約について
06/282,6902,7142,6702,708-0.77%17,400779億9040万-2.03%
06/272,6922,7452,6922,729+1.3%15,400785億9520万-1.55%
06/262,7022,7092,6842,694-0.81%14,100775億8720万-2.99%
06/252,7432,7432,7052,716-0.04%20,300782億2080万-2.37%
06/222,7372,7612,7012,717-1.63%34,400782億4960万-2.55%
06/212,7592,7962,7552,762-0.79%11,400795億4560万-1.15%
06/202,7642,7862,7582,784+0.14%16,000801億7920万-0.54%
06/192,7982,8112,7542,780-0.93%20,500800億6400万-0.89%
06/182,8412,8542,7922,806-1.23%7,700808億1280万-0.28%
06/152,8382,8642,8282,841+0.78%28,500818億2080万+0.71%
06/142,7852,8242,7852,819+0.46%11,100811億8720万-0.07%
06/132,8302,8502,7602,806-0.11%21,300808億1280万-0.53%
06/122,7812,8172,7502,809+1.85%39,200808億9920万-0.43%
06/112,7582,7822,7462,7580%19,500794億3040万-2.3%